Search

everythinglearnresearchcommunity

for

Search:↓

A new mutation in the human glucocorticoid receptor reduces its function and causes resistance to glucocorticoids.

Low-dose DMSO may help treat castration-resistant prostate cancer by reducing key cancer cell receptors.

AR polyglycine repeat doesn't cause baldness.

Gene differences affect finasteride side effects in men with hair loss.

Melatonin receptor genes likely play an important role in the development of goose feather follicles.

Progesterone and its byproducts control a specific receptor in the brain independently of progesterone receptors, affecting conditions related to the menstrual cycle.

The Hairless gene is crucial for healthy skin and hair growth.

Blocking testosterone speeds up wound healing in males.

Androgen receptors are active in many tissues of both male and female mice, not just reproductive organs.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Hair sensitivity to androgens is partly controlled by specific enzyme expressions in different hair areas.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

Androgen receptor inactivation delays skin cancer onset and reduces incidence in mice, with gender differences in susceptibility.

Finasteride-treated male rats' offspring had altered glucose metabolism, potentially increasing diabetes risk.

Hair loss in androgenic alopecia may be linked to increased local androgen activities, but not to estrogen levels.

Scientists at the University of Michigan Medical School successfully created a special compound that can be used to improve imaging of prostate cancer.

Early androgen exposure affects hormone receptor expression in adult female rats' brains, but not in males.

Androgen receptors in the mouse brain may explain cognitive and mood changes in prostate cancer treatment.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

Androgen receptors in the brain affect metabolism and reproduction differently in males and females, and may help manage PCOS symptoms in females.

Blocking androgen receptors early in life increases estrogen levels and reduces sexual motivation in male rats.

Activating androgen receptors in muscle can increase muscle mass and reduce fat.

A new treatment using nanoliposomes can improve hair regrowth in androgenetic alopecia.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

Estrogen Receptor ß (ERß) is the main hormone controller in human skin and hair follicles, not Estrogen Receptor α (ERα) or the Androgen Receptor (AR).